chr22-41152004-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001429.4(EP300):​c.2989A>G​(p.Ile997Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.283 in 1,613,848 control chromosomes in the GnomAD database, including 71,539 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.23 ( 5329 hom., cov: 31)
Exomes 𝑓: 0.29 ( 66210 hom. )

Consequence

EP300
NM_001429.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8O:1

Conservation

PhyloP100: 2.95

Publications

91 publications found
Variant links:
Genes affected
EP300 (HGNC:3373): (E1A binding protein p300) This gene encodes the adenovirus E1A-associated cellular p300 transcriptional co-activator protein. It functions as histone acetyltransferase that regulates transcription via chromatin remodeling and is important in the processes of cell proliferation and differentiation. It mediates cAMP-gene regulation by binding specifically to phosphorylated CREB protein. This gene has also been identified as a co-activator of HIF1A (hypoxia-inducible factor 1 alpha), and thus plays a role in the stimulation of hypoxia-induced genes such as VEGF. Defects in this gene are a cause of Rubinstein-Taybi syndrome and may also play a role in epithelial cancer. [provided by RefSeq, Jul 2008]
EP300-AS1 (HGNC:50504): (EP300 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.5753508E-4).
BP6
Variant 22-41152004-A-G is Benign according to our data. Variant chr22-41152004-A-G is described in ClinVar as Benign. ClinVar VariationId is 93736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.412 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EP300NM_001429.4 linkc.2989A>G p.Ile997Val missense_variant Exon 15 of 31 ENST00000263253.9 NP_001420.2 Q09472Q7Z6C1
EP300NM_001362843.2 linkc.2911A>G p.Ile971Val missense_variant Exon 14 of 30 NP_001349772.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EP300ENST00000263253.9 linkc.2989A>G p.Ile997Val missense_variant Exon 15 of 31 1 NM_001429.4 ENSP00000263253.7 Q09472

Frequencies

GnomAD3 genomes
AF:
0.231
AC:
35091
AN:
152024
Hom.:
5319
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0585
Gnomad AMI
AF:
0.427
Gnomad AMR
AF:
0.420
Gnomad ASJ
AF:
0.321
Gnomad EAS
AF:
0.0583
Gnomad SAS
AF:
0.373
Gnomad FIN
AF:
0.318
Gnomad MID
AF:
0.239
Gnomad NFE
AF:
0.275
Gnomad OTH
AF:
0.259
GnomAD2 exomes
AF:
0.310
AC:
77896
AN:
251398
AF XY:
0.309
show subpopulations
Gnomad AFR exome
AF:
0.0532
Gnomad AMR exome
AF:
0.599
Gnomad ASJ exome
AF:
0.327
Gnomad EAS exome
AF:
0.0626
Gnomad FIN exome
AF:
0.314
Gnomad NFE exome
AF:
0.279
Gnomad OTH exome
AF:
0.328
GnomAD4 exome
AF:
0.289
AC:
421891
AN:
1461706
Hom.:
66210
Cov.:
36
AF XY:
0.291
AC XY:
211498
AN XY:
727158
show subpopulations
African (AFR)
AF:
0.0483
AC:
1617
AN:
33480
American (AMR)
AF:
0.576
AC:
25778
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.327
AC:
8538
AN:
26130
East Asian (EAS)
AF:
0.0414
AC:
1644
AN:
39698
South Asian (SAS)
AF:
0.374
AC:
32238
AN:
86242
European-Finnish (FIN)
AF:
0.318
AC:
16998
AN:
53418
Middle Eastern (MID)
AF:
0.285
AC:
1646
AN:
5768
European-Non Finnish (NFE)
AF:
0.285
AC:
316463
AN:
1111860
Other (OTH)
AF:
0.281
AC:
16969
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
16470
32941
49411
65882
82352
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10606
21212
31818
42424
53030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.231
AC:
35108
AN:
152142
Hom.:
5329
Cov.:
31
AF XY:
0.240
AC XY:
17831
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.0583
AC:
2421
AN:
41530
American (AMR)
AF:
0.421
AC:
6428
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.321
AC:
1112
AN:
3466
East Asian (EAS)
AF:
0.0582
AC:
302
AN:
5188
South Asian (SAS)
AF:
0.374
AC:
1804
AN:
4828
European-Finnish (FIN)
AF:
0.318
AC:
3362
AN:
10562
Middle Eastern (MID)
AF:
0.236
AC:
69
AN:
292
European-Non Finnish (NFE)
AF:
0.275
AC:
18681
AN:
67988
Other (OTH)
AF:
0.256
AC:
540
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1272
2544
3816
5088
6360
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
364
728
1092
1456
1820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.261
Hom.:
17612
Bravo
AF:
0.234
TwinsUK
AF:
0.298
AC:
1106
ALSPAC
AF:
0.275
AC:
1059
ESP6500AA
AF:
0.0604
AC:
266
ESP6500EA
AF:
0.280
AC:
2411
ExAC
AF:
0.296
AC:
35902
Asia WGS
AF:
0.176
AC:
613
AN:
3478
EpiCase
AF:
0.287
EpiControl
AF:
0.277

ClinVar

Significance: Benign
Submissions summary: Benign:8Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3Other:1
Jun 10, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Rubinstein-Taybi syndrome due to EP300 haploinsufficiency Benign:2
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Jul 17, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 22231458) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Menke-Hennekam syndrome 2 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
9.4
DANN
Benign
0.77
DEOGEN2
Benign
0.34
T
Eigen
Benign
-0.74
Eigen_PC
Benign
-0.63
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Benign
0.59
T
MetaRNN
Benign
0.00016
T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
0.0
N
PhyloP100
2.9
PrimateAI
Benign
0.30
T
PROVEAN
Benign
0.35
N
REVEL
Benign
0.24
Sift
Benign
0.31
T
Sift4G
Benign
0.39
T
Polyphen
0.0
B
Vest4
0.014
ClinPred
0.0097
T
GERP RS
3.6
Varity_R
0.029
gMVP
0.061
Mutation Taster
=91/9
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs20551; hg19: chr22-41548008; COSMIC: COSV54330294; COSMIC: COSV54330294; API